Gema Sánchez‐Martín

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Early Treatment with Metformin Improves Neurological Outcomes in Lafora Disease”.

Early Treatment with Metformin Improves Neurological Outcomes in Lafora Disease

Neurotherapeutics(2022)10.1007/s13311-022-01304-w

N/A

0DataRank · unranked

26 citations

María Machío-Castello, Nerea Iglesias‐Cabeza, Beatriz G. Giráldez, Juan González‐Fernández, Gema Sánchez‐Martín +3 more

Epm2aR240X knock-in mice present earlier cognitive decline and more epileptic activity than Epm2a mice

Neurobiology of Disease(2023)10.1016/j.nbd.2023.106119

N/A

0DataRank · unranked

9 citations

Miriam Sciaccaluga, Carolyn A. Worby, Luis Zafra‐Puerta, Nerea Iglesias‐Cabeza, Gema Sánchez‐Martín +5 more

Gene replacement therapy for Lafora disease in the Epm2a -/- mouse model

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.14.571636

N/A

0DataRank · unranked

1 citations

Daniel F. Burgos, Nerea Iglesias‐Cabeza, Juan González‐Fernández, Gema Sánchez‐Martín, Marina P. Sánchez +2 more

Gene therapy for Lafora disease in the Epm2a mouse model

Molecular Therapy(2024)10.1016/j.ymthe.2024.05.032

N/A

0DataRank · unranked

15 citations

Nerea Iglesias‐Cabeza, Daniel F. Burgos, Miriam Sciaccaluga, Juan González‐Fernández, Laura Bellingacci +6 more

Effect of intracerebroventricular administration of alglucosidase alfa in two mouse models of Lafora disease: Relevance for clinical practice

Epilepsy Research(2024)10.1016/j.eplepsyres.2024.107317

N/A

0DataRank · unranked

7 citations

Matthieu Colpaert, Nerea Iglesias‐Cabeza, Daniel F. Burgos, Gema Sánchez‐Martín, Matthew S. Gentry +3 more